Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMC 4601774)

Published in PLoS One on October 12, 2015

Authors

Otso Arponen1, Otso Arponent, Mazen Sudah2, Amro Masarwah1, Mikko Taina1, Suvi Rautiainen1, Mervi Könönen2, Reijo Sironen3, Veli-Matti Kosma3, Anna Sutela2, Juhana Hakumäki2, Ritva Vanninen4

Author Affiliations

1: Kuopio University Hospital, Diagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland; University of Eastern Finland, Institute of Clinical Medicine, School of Medicine, Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland.
2: Kuopio University Hospital, Diagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland.
3: Kuopio University Hospital, Department of Pathology, Kuopio University Hospital, Kuopio, Finland; University of Eastern Finland, Institute of Clinical Medicine, School of Medicine, Department of Clinical Pathology and Forensic Medicine, Kuopio University Hospital, Kuopio, Finland; University of Eastern Finland, Cancer Center of Eastern Finland, Kuopio, Finland.
4: Kuopio University Hospital, Diagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland; University of Eastern Finland, Institute of Clinical Medicine, School of Medicine, Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland; University of Eastern Finland, Cancer Center of Eastern Finland, Kuopio, Finland.

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet (2012) 4.76

Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (2012) 3.56

Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology (2006) 3.40

Confirmation of a prognostic index in primary breast cancer. Br J Cancer (1987) 3.29

An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat (2007) 2.65

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed (2009) 1.91

Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol (2009) 1.91

Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. J Magn Reson Imaging (2009) 1.68

Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology (2009) 1.67

Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology (1994) 1.46

Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol (2011) 1.38

Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36

Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging (2009) 1.21

Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol (2011) 1.17

Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed (2010) 1.14

Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging (2011) 1.11

Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology (2014) 1.10

FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging (2010) 1.07

Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol (2010) 1.06

Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology (2011) 1.01

Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging. Magn Reson Med Sci (2010) 1.00

Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions. Eur J Radiol (2013) 0.97

MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol (2002) 0.96

Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol (2014) 0.95

Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy. Radiology (2013) 0.94

Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla. J Magn Reson Imaging (2013) 0.93

Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. Magn Reson Med Sci (2013) 0.93

Study of the reduced field-of-view diffusion-weighted imaging of the breast. Clin Breast Cancer (2013) 0.90

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol (2005) 0.87

Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI. Clin Radiol (2013) 0.86

Diffusion-weighted MR imaging of benign and malignant breast lesions before and after contrast enhancement. Rofo (2013) 0.86

Comment on ADC reductions in postcontrast breast tumors. J Magn Reson Imaging (2010) 0.84

Diffusion-weighted breast imaging at 3 T: preliminary experience. Clin Radiol (2013) 0.84

Quantification of abdominal aortic aneurysm wall enhancement with dynamic contrast-enhanced MRI: feasibility, reproducibility, and initial experience. J Magn Reson Imaging (2013) 0.83

Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. Tumour Biol (2013) 0.81

Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis? Radiology (2005) 0.79